Carnett sign is a classic clinical physical examination maneuver designed to differentiate abdominal pain originating from the abdominal wall (parietal origin) from pain arising within the intra-abdominal viscera2,6. First described by John B. Carnett in 1926, this test relies on the anatomical principle that when the abdominal wall musculature is contracted, superficial somatic pain structures remain exposed or compressed within the tense muscle layer, whereas intra-abdominal visceral pain is shielded and thus mitigated by the contracting muscular wall2,4. Utilizing Carnett sign in clinical practice prevents misattribution of abdominal wall syndromes—such as chronic abdominal wall pain (CAWP) and anterior cutaneous nerve entrapment syndrome (ACNES)—to visceral pathologies, thereby sparing patients from exhaustive, costly diagnostic workups and unnecessary surgical interventions2,4,5.

Etiology & Risk Factors

  • Anterior Cutaneous Nerve Entrapment Syndrome (ACNES): The most common specific etiology of chronic abdominal wall pain, caused by entrapment of the terminal branches of the lower intercostal nerves (T7–T12) as they pierce the rigid rectus abdominis muscle sheath2,4.
  • Myofascial Trigger Points: Focal areas of hyperirritability within skeletal muscle fibers or fascia, frequently precipitated by repetitive microtrauma, poor posture, or acute muscle strain3.
  • Structural and Traumatic Conditions: Rectus sheath hematomas resulting from direct abdominal trauma, strenuous coughing, or anticoagulant therapy; surgical scar neuromas; and incisional, umbilical, or inguinal hernias3.
  • Localized Endometriosis: Implantation of endometrial tissue within previous surgical scars (e.g., cesarean section scars) or the abdominal wall musculature, presenting with cyclical pain3.
  • Demographic and Systemic Risk Factors: Higher prevalence among middle-aged adults, with a notable female predominance (frequently linked to pregnancy-related ligamentous and fascial strain or previous abdominal procedures)4.

Pathophysiology

The pathophysiology underlying a positive Carnett sign involves the anatomical separation of somatic versus visceral sensory innervation2. The abdominal wall—comprising the skin, subcutaneous tissue, rectus abdominis and oblique muscles, and parietal peritoneum—is innervated by somatic sensory fibers from the lower intercostal nerves (T7 through T12) and the ilioinguinal and iliohypogastric nerves (L1). In conditions such as ACNES, these neural branches become acutely angulated, compressed, or sheared as they traverse rigid fascial apertures or fibrous rings, particularly at the lateral edge of the rectus muscle sheath. When the patient performs an active sit-up or raises their head and shoulders against resistance, the rectus abdominis and oblique muscles contract forcefully. In visceral pain syndromes, this contraction creates a muscular shield or barrier that protects inflamed underlying intra-abdominal organs from direct palpation, resulting in decreased tenderness. Conversely, when the pain originates within the abdominal wall itself, muscle contraction directly compresses the entrapped cutaneous nerves or inflamed myofascial fibers against the contracting muscle mass, maintaining or significantly exacerbating the focal tenderness—yielding a positive Carnett sign2,3,4.

Carnett sign — Pathophysiological Cascade & Clinical Flowchart 1 Trigger / Primary Insult Mechanical irritation, fascial strain, or cutaneous nerve entrapment along the abdominal wall. 2 Cellular / Pathophysiological Cascade Localized inflammation, ischemic compression, and sensitization of somatic sensory nerve fibers in the rectus abdominis or oblique muscles. 3 Target Organ / Structural Change Irritation of the anterior cutaneous branches of intercostal nerves as they traverse rigid fascial rings. 4 Hallmark Clinical & Diagnostic Manifestation Focal abdominal tenderness that remains unchanged or intensifies during active abdominal wall contraction (positive Carnett sign). 5 Complications if Untreated & Therapeutic Target Chronic debilitating pain leading to unnecessary diagnostic testing and surgical explorations; targeted with local anesthetic infiltration.

Clinical Presentation & Classic Clinical Signs

  • History & Cardinal Symptoms: Patients typically present with localized, sharp, burning, or constant aching abdominal pain that is frequently unremitting and bears little to no relationship to meals, bowel function, or defecation3. Symptoms often exhibit a clear relationship to posture, twisting movements, or physical activity, and patients can frequently point to a tiny, highly localized spot of maximal discomfort with a single finger (Carnett's pointing sign)3,4.
  • Physical Examination & Named Clinical Signs: The examiner first palpates the abdomen while relaxed to locate the point of maximum tenderness. The patient is then asked to lift their head and shoulders off the examination table (or raise their legs straight) to contract the rectus abdominis muscles without using arm support. If the previously identified point of tenderness remains unchanged or increases markedly during this maneuver, Carnett sign is positive, indicating a somatic abdominal wall etiology2,3. Sensory mapping may reveal an area of hyperesthesia, hypoesthesia, or altered pinprick sensation in the distribution of the affected intercostal nerve.

Diagnostic Workup & Interpretation (Laboratory, Imaging & ECG/Pathology)

Diagnostic Modality / Test Expected Clinical & Radiological / Laboratory Finding
Gold-Standard InvestigationTargeted diagnostic infiltration of the painful trigger point with 1 to 5 mL of a short-acting local anesthetic (e.g., 1% lidocaine without epinephrine), resulting in immediate and complete or near-complete resolution of pain2,3,4.
Laboratory PanelComplete blood count (CBC), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and comprehensive metabolic panel are typically entirely normal, helping to exclude systemic inflammatory, infectious, or visceral disease4.
Imaging / Radiology (X-ray, US, CT, MRI)Abdominal ultrasound or computed tomography (CT) scans are generally normal when evaluating ACNES or myofascial pain, but are critical to rule out structural anomalies such as occult hernias, rectus sheath hematomas, or intra-abdominal pathology3,4.
ECG / Histopathology / ProceduralElectrocardiogram and cardiac enzymes should be assessed if upper abdominal wall pain mimics cardiac ischemia; histopathology (if surgically resected) may reveal perineural fibrosis or nerve entrapment within scar tissue in refractory cases2.

Staging, Classification & Clinical Scoring Systems

Criterion / Stage / Score Component Clinical Threshold, Points & Management Implication
ACNES Diagnostic CriteriaPresence of sharp, localized abdominal wall pain; positive Carnett sign; localized hyperesthesia or sensory loss on physical exam; and dramatic pain relief following diagnostic local anesthetic infiltration2,4,5.
Pain Chronicity & Severity ScaleMild (intermittent, responsive to oral analgesics and activity modification); Moderate (persistent, requiring periodic trigger point injections); Severe/Refractory (debilitating, requiring chemical neurolysis or surgical neurectomy)2,4.

Differential Diagnosis

Differential Condition Distinguishing Clinical, Biochemical & Imaging Features
Acute / Chronic AppendicitisVisceral pain localized to the right lower quadrant; associated with nausea, vomiting, leukocytosis, and fever; tenderness usually decreases with abdominal wall contraction (negative Carnett sign)2.
Peptic Ulcer Disease / GastritisEpigastric discomfort closely related to food intake, meals, or antacid administration; visceral origin with a negative Carnett sign; confirmed via endoscopy3,4.
Irritable Bowel Syndrome (IBS)Diffuse, crampy abdominal pain associated with altered bowel habits (diarrhea and/or constipation); lacks focal abdominal wall trigger points and exhibits a negative Carnett sign3,6.
Occult Abdominal Wall HerniaSpigelian, inguinal, or incisional hernia presenting with a palpable fascial defect and a positive Carnett sign; definitively diagnosed via ultrasound or CT scanning3,4.

Management & Treatment Protocol

  • Initial Stabilization & Resuscitation: Reassure the patient regarding the benign, non-visceral nature of the pain to alleviate anxiety and reduce the cycle of chronic pain perception; initiate activity modification to avoid aggravating physical triggers4.
  • First-Line Medical / Pharmacological Therapy (with exact adult dosing): Prescribe oral analgesics such as non-steroidal anti-inflammatory drugs (NSAIDs)—e.g., ibuprofen 400 mg to 800 mg orally every 8 hours with food (maximum 2,400 mg/day) or naproxen 500 mg orally twice daily—alongside topical lidocaine 5% patches applied over the maximal tender spot for 12 hours on and 12 hours off4.
  • Surgical / Interventional Indications: Administer targeted trigger point infiltration using 1 to 5 mL of 1% lidocaine or 0.5% bupivacaine, often combined with 40 mg of triamcinolone or methylprednisolone acetate for sustained anti-inflammatory effect. For refractory cases failing conservative and injection therapy, surgical anterior neurectomy or chemical neurolysis (e.g., pulsed radiofrequency ablation) is indicated2,4,5.

Complications & Prognosis

  • Key complications of unrecognized chronic abdominal wall pain include prolonged patient suffering, frequent and unnecessary emergency department visits, redundant diagnostic imaging, invasive exploratory procedures (such as diagnostic laparoscopy), and the development of chronic pain syndromes complicated by polypharmacy or opioid dependence2,4,5.
  • Prognosis is generally favorable once the correct diagnosis is established via a positive Carnett sign and confirmed with local anesthetic infiltration; a significant majority of patients achieve durable relief through conservative care and targeted trigger point injections4,6.